Find a clinical trial

FindClinicalTrial

If you have questions about clinical trials or want help finding the right one for you, contact our:

Patient Engagement Center Phone: 844-552-2734

This is a preliminary search of all open and enrolling clinical trials across our regions and affiliate organizations that have sponsors' permission to publish to this website.

Please use the filtering options in the right column to refine your search. Otherwise ALL open and enrolling clinical trials will display below.

Viewing Page 2 of 27 | Showing Results 6 - 10 of 135

A Phase 1/2 Study of the Safety, Pharmacokinetics, and Anti-Tumor Activity of the Oral EGFR/HER2 Inhibitor AP32788 in Non-Small Cell Lung Cancer

General Inclusion Criteria (all dose escalation and expansion cohorts):• Have histologically or cytologically confirmed locally advanced (and not a...

Min Sung Park, M.D.
  • Swedish Medical Center

Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Stage I-III Limited Disease Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy (ADRIATIC)

Inclusion criteria:1.Histologically or cytologically documented limited-stage small cell lung cancer (stage I-III).2.Received 4 cycles of...

Basir Haque, M.D.
  • Kadlec Clinic Hematology and Oncology
  • Kadlec Research

Randomized, Phase 3 Study of Tesetaxel Plus a Reduced Dose of Capecitabine Versus Capecitabine Alone in Patients With HER2 Negative, HR Positive, Locally Advanced or Metastatic Breast Cancer Previously Treated With a Taxane

Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, MBC (CONTESSA)Inclusion Criteria:• HER2 negative...

Erin Ellis, M.D.
  • Swedish Medical Center

A randomized phase II study to evaluate efficacy of T-DM1 with or without Palbociclib in the treatment of patients with metastatic HER2 positive breast cancer

Inclusion Criteria:Be informed of the investigational nature of the study and all pertinent aspects of the trialSign and provide written consent in...

Henry Kaplan, M.D.
  • Swedish Medical Center

An Open-Label, Single-Arm, Phase 2 Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery

Inclusion Criteria:DCIS or Stage I-III primary invasive carcinoma of the breastPrimary surgical treatment is lumpectomy + SLNB or ALND --or--...

Claire Buchanan, M.D., FACS
  • Swedish Medical Center
Viewing Page 2 of 27 | Showing Results 6 - 10 of 135